Page 4 - Hdfc Life

HDFC Life invests in 'Z3Partners Tech Fund' to aid digital entrepreneurs

Z3 Partners has already backed startups like Cyfirma, DealShare, Gramophone, Shipsy, and True-Fan

Xanadu Realty raises undisclosed sum from HDFC, HDFC Life for expansion

Xanadu Realty Ltd, a realty tech business accelerator firm, on Tuesday announced that it has received a strategic investment from HDFC Ltd and HDFC Life Insurance Co. Ltd.

HDFC Life March quarter: Guidance of premium growth offers confidence

Analysts' target price tops Rs 600

Rainbow Medicare raises Rs 470 cr from anchor investors ahead of IPO

Close to 8.7 million shares were alloted to 36 institutional investors at Rs 542 per share, the upper end of the price band

HDFC Life's net profit jumps 12% to Rs 357 cr; VNB margins at 29.3%

The firm settled some 390,000 claims in FY22, with gross and net claims paid of Rs 5,804 cr and Rs 4,328 cr, respectively. It was carrying excess mortality reserves of Rs 55 cr at the end of Q4

Stocks to Watch: Bajaj Finance, Tata Motors, GMDC, HDFC Life, YES Bank

Stocks to Watch today: Bajaj Finance, HDFC Life, Macrotech Developers, KPIT Technologies are among those slated to announce their Q4 earnings today.

HDFC Bank writes to RBI, seeks approval to hold 50% stake in HDFC Life

Lender wants either be allowed to hold a 47.82 per cent stake HDFC Ltd in the insurer or buy additional stake in the company from the market

SBI Life, HDFC Life shares jump on reports of likely delay in LIC IPO

SBI Life shares settled 5.7 per cent higher at Rs 1,120, whereas HDFC Life 7.0 per cent up at Rs 560

LIC's business plan change after IPO a threat to private firms: Report

According to an analysis of its initial public offer (IPO) filings by Swiss brokerage Credit Suisse, SBI Life, ICICI Prudential, HDFC Life and Max Life will face the maximum impact of the LIC move

ICICI Prudential, HDFC Life Insurance opt for higher retention on books

An increase in retention limit means the insurer increases the degree of risk it retains on its balance sheet

HDFC Life hits 52-week low on lower-than-expected December quarter results

In Q3FY22, the company's gross premium income remained healthy with a 27 per cent increase to Rs 12,255 crore, led by traction in renewal premium and new business premium.

HDFC Life reports 3.3% rise in net profit to Rs 273.7 cr for Dec quarter

Its gross premium income remained healthy with a 27 per cent increase to Rs 12,255 crore, led by traction in renewal premium and new business premium

HDFC Life Q3 net profit rises 3% to Rs 274 cr

However, total income declined to Rs 14,222.22 crore in the latest December quarter from Rs 21,126.80 crore in October-December 2020

HDFC Life completes acquisition of Exide Life; merger to take place shortly

'The acquisition will accelerate the scale-up of the proprietary channels, strengthen presence in South India and across tier 2 and tier 3 locations,' HDFC Life said

Sensex slips 257pts, Nifty below 17,850; Airtel, ICICI, HDFC Bank weigh

The broader markets moved in tandem with the key benchmark indices. The BSE Midcap and Smallcap indices were down 0.2 per cent and 0.3 per cent, respectively.

Insurance companies apply big in Policy Bazaar's Rs 5,600 crore IPO

A total of 26.2 million shares have been allocated to over 150 funds at Rs 980 per share

HDFC Life profit falls 16% in Q2 on account of high Covid-19 claims

Net premium increased 14 per cent to Rs 11,443.96 crore against Rs 10,045.44 crore a year ago

HDFC Life Q2 consolidated net profit declines 16% to Rs 275.91 cr

HDFC Life Insurance on Friday reported a nearly 16 per cent decline in consolidated net profit to Rs 275.91 crore in the second quarter ended September 30.

Exide Life is a tuck-in acquisition at fair valuations: HDFC Life CEO

In a Q&A, the MD & CEO of HDFC Life dwelt on the contours of her company's acquisition of Exide Life Insurance and how it will help HDFC Life consolidate its position in the industry

Don't see term product prices rising: HDFC Life MD & CEO Vibha Padalkar

Vibha Padalkar talks about the adequacy of reserves the company set aside for future claims and the impact of higher claims on term prices, among others